Report International

11/28/2025

Check out our November Newsletter here:https://reportinternational.org/wp-content/uploads/2025/11/RePORT-November-2025-Newsletter.pdf

11/24/2025

Important diagnostic news for the TB community: Cepheid has announced that the World Health Organization (WHO) has prequalified the Xpert MTB/XDR test, a significant step forward for expanding access to rapid drug-resistance testing. This prequalification supports wider procurement and use of the assay, enabling countries to more effectively detect resistance to key TB drugs and strengthen clinical decision-making.

Read more: https://www.prnewswire.com/news-releases/cepheid-announces-world-health-organization-prequalification-of-the-xpert-mtbxdr-test-302595981.html

/PRNewswire/ -- Cepheid today announced that its Xpert® MTB/XDR test has been awarded prequalification status by the World Health Organization (WHO), marking a...

11/17/2025

Why is tuberculosis still around when we already have a cure? NPR’s Shortwave podcast explores this question in a recent episode, delving into the scientific, historical, and social factors that make TB one of the world’s most persistent infectious diseases. It’s an accessible and thought-provoking look at the intersection of medicine, inequality, and global health.

Take a listen: https://www.npr.org/2025/10/21/nx-s1-5552528/medical-history-science-tuberculosis-john-green

Tuberculosis – the world’s deadliest infectious disease – could be dormant in your system for years before you realize you have it. In the U.S., it’s relatively rare; provisional data shows that there were just over 10,000 cases in 2024. But in other parts of the world, especially lower-inco...

11/14/2025

“If primary care doesn’t reach priority populations, it isn’t primary care.”

In their recent The Lancet Regional Health commentary, Drs. Bruno Andrade and Beatriz Barreto Duarte call for a transformation in how primary care is delivered, emphasizing care that is person-centered, team-based, data-literate, and deeply connected to social protection.

Read the full commentary: https://www.thelancet.com/journals/lanprc/article/PIIS3050-5143(25)00067-6/fulltext

Primary care is the foundation of equitable health systems. It not only serves as the entry point to care but also ensures continuity of care over time and embraces a model of patient-centredness, delivering services that respond to individual needs and social realities. By doing so, primary care bu...

11/12/2025

RePORT Brazil’s Drs. Bruno Andrade and Mariana Araújo-Pereira have published an insightful essay exploring how immunology can illuminate human relationships. The essay draws parallels between cytokine communication and language.

Read more in Trends in Immunology: https://www.sciencedirect.com/science/article/pii/S1471490625002479

11/10/2025

Climate change and tuberculosis are increasingly interconnected public health challenges.

Climate change affects the diagnosis, treatment, and transmission of TB through complex and overlapping pathways, as described in the WHO Framework on Climate Change and Health. A new analytical framework published in The Lancet Respiratory Medicine offers guidance for governments to better understand and address these interactions, supporting more resilient health systems in the face of environmental change.

Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00329-7/fulltext

Climate change is likely to exacerbate a range of determinants that drive tuberculosis, the world's leading cause of death from a single infectious agent. However, tuberculosis is often neglected in wider climate health discussions. Commissioned by WHO, we developed an analytical framework outlining...

11/10/2025

Dr. Amita Gupta, RePORT India and RICC PI, co-chaired “Launch of TB and pregnancy consensus statement and call to action” on October 30. The consensus statement and call to action can be found at the following links:

Consensus Statement: Optimal and early inclusion of pregnant and lactating women in tuberculosis research
Call to Action: Accelerating research to end tuberculosis in pregnant and lactating women
https://www.who.int/publications/i/item/9789240112858

11/06/2025

From the Archives: Partner Network Spotlight – Tuberculosis Research Advancement Centers (TRACs)

The Tuberculosis Research Advancement Centers (TRACs) are advancing interdisciplinary TB research and training across U.S. institutions by fostering collaboration, mentorship, and capacity-building. Each TRAC serves as a hub that connects basic, clinical, and population-based investigators, supporting innovative approaches to address key challenges in TB science.

Learn more about how the TRACs strengthen research networks and contribute to global TB control efforts: https://reportinternational.org/partner-network-spotlight/

Partner Network Spotlight

11/04/2025

Dr. Amita Gupta, Director of the Johns Hopkins Division of Infectious Diseases and Executive Committee Chair, recently co-chaired a webinar launching the World Health Organization’s consensus statement on the optimal and early inclusion of pregnant and lactating women in tuberculosis research, along with an accompanying call to action.

In 2024, the WHO Global Programme on Tuberculosis & Lung Health (WHO/GTB) led an extensive consensus-building process to advance equitable inclusion of pregnant women in TB research—aligning with global efforts to transform clinical trial practices and address the needs of underrepresented populations. The resulting statement reflects the work of five thematic groups covering preclinical research, therapeutics, vaccines, maternal TB surveillance, and advocacy, with recommendations for both cross-cutting and topic-specific approaches.

Learn more about this important step toward inclusive and evidence-driven TB research: https://www.who.int/publications/i/item/9789240112858

In 2024, the World Health Organization Global Programme on Tuberculosis & Lung Health (WHO/GTB) led a consensus building process to advance the earlier and optimal inclusion of pregnant women in TB research. The process is aligned with broader global developments to transform clinical trial practice...

10/30/2025

From the Archives: Introducing the New RICC Post-Doctoral Fellows & Future Leaders

The RePORT International Coordinating Center (RICC) supports two capacity-building programs designed to strengthen the next generation of TB researchers — the Post-Doctoral Fellows and Future Leaders programs. Both are highly competitive, with selection based on proposed research, skills development plans, and mentor recommendations.

We’re proud to highlight the most recent cohort of emerging investigators who are advancing tuberculosis science through collaboration, innovation, and leadership.

Read more: https://reportinternational.org/next-gen-tb-researchers/

Next Gen TB Researchers

10/28/2025

Congratulations to Investigator Dr. Jinsoo Min!

Professor Jinsoo Min, Division of Pulmonology, Department of Internal Medicine, Seoul St. Mary’s Hospital, has been selected as the recipient of the 2025 Asia TB Future Investigator Award. The award will be presented at the 8th Asia Forum for TB Elimination Cooperation, scheduled for October 17.

This award recognizes emerging leaders in tuberculosis research across the Asia-Pacific region who have demonstrated excellence in scientific achievement and a strong commitment to advancing TB control and elimination.

Read more: https://www.linkedin.com/posts/minjinsoo_tuberculosis-activity-7384191517483028480-4Qzl/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAEQZCPkB2PWtCFD-2p81wzk-2_wBtcrfA7E

10/28/2025

Congratulations to our colleagues in , , and !

Their recent publication, “Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countries,” contributes valuable evidence on pediatric TB treatment and medication acceptability, which is an essential factor in improving adherence and outcomes for children affected by drug-resistant tuberculosis.

Read the full article here: https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000010/art00007 #